In addition to federal regulations, much of the regulation on opiate prescribing is governed on the state level. As such, many states have generated state specific policies that providers need to be familiar with when prescribing opiates. Several states have even mandated urine drug screening as a necessary component for treatment with long term opioid therapy. Please reference the clickable state map to link to your state's specific regulatory guidelines.
FSMB maintains a policy named the Model Policy For the Use of Controlled Substances for the Treatment of Pain. Many of the states with no specific state information defer to the FSMB policy.
The DEA publishes and maintains a manual named the Practitioner's Manual, an Informational Outline of the Controlled Substances Act to help clinicians understand how the CSA pertains to them.
APS/AAPM have published a set of guidelines named the Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain.
Legal Disclaimer: As a service to our clients, every effort is made to keep these links active and up-to-date. The information contained herein is intended to be an educational summary of regulatory material and is not to be construed as legal advice. It is the responsibility of the prescribing clinician to ensure compliancy to all local, state, and federal laws/regulations. Premier Screening is in no way affiliated with any of the state medical boards, the Federation of State Medical Boards, the Drug Enforcement Adminsitration, the American Pain Society, or the American Academy of Pain Medicine.